3.38
+16.55%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Quanterix
From its filings with the US Securities and Exchange Commission
Quanterix is based in Billerica, Massachusetts and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker QTRX. The SEC classifies its business as laboratory analytical instruments. In the fiscal year to 31 December 2025, it reported revenue of $138.9m and a net loss of $107.2m. At that date it held total assets of $418.8m and shareholders' equity of $295.7m.
We are a life sciences company transforming healthcare innovation by accelerating biomarker breakthroughs from discovery to diagnostics using our ultra-sensitive translational research and spatial biology instruments, consumables, and services. We continue to invest in pushing a paradigm shift in healthcare from an emphasis on later-stage treatment to a focus on earlier detection, monitoring, prognosis, and, ultimately, prevention. Our combined platforms have achieved significant commercial adoption with an installed base of over 2,500 instruments and scientific validation with citations in more than 6,200 scientific publications in areas of high unmet medical need and research interest such as neurology, oncology, immunology, and inflammation.
Our proprietary digital “Simoa” detection technology enables customers to reliably detect protein biomarkers at ultra-low concentrations in blood, serum and other fluids that, in many cases, are undetectable using conventional, analog immunoassay technologies. Multi-plexing biomarker analysis in tissue samples with our “Spatial Biology” platforms enables scientists to understand the localized interactions occurring on the cellular level. We believe our combination of technologies will enable scientists to help drive diagnostic innovation in the evolving healthcare landscape with data across the tissue to fluid continuum.
Quoted from its 10-K, filed 2 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 7 Dec 2017
- Employees
- 450
- Website
- quanterix.com ↗
- Head office
- 900 MIDDLESEX TURNPIKE, BILLERICA, MA, 01821
- Incorporated in
- DE
- Classification
- Laboratory Analytical Instruments
- Filer status
- Accelerated filer
Leadership
Pay as last reported
- Mr. William DonnellyNon-Executive Chairman of the Board, since 2023$251,269
- Mr. Everett CunninghamPresident, Chief Executive Officer, Director, since 2026
- Dr. Masoud TolouePresident, Chief Executive Officer, Director, since 2021$6.4m
- Ms. Vandana SriramChief Financial Officer, Treasurer$2.6m
- Mr. Jeffrey ElliottLead Independent Director$415,968
- Dr. Myla LaigoldmanDirector
- Mr. Scott MendelDirector
- Dr. Ivana Magov Evi-liebischIndependent Director$411,747
- Ms. Karen FlynnIndependent Director$256,813
- Dr. Garret HamptonIndependent Director
- Dr. Alan SachsIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 47
- Environment
- 53
- Social
- 39
- Governance
- 50
- Women in the workforce
- 43%
- Carbon reduction policy
- No
- Human rights policy
- No
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.